Olin Liang

10PUBLICATIONS
32CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityAerodynamics (excl. hypersonic aerodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 25, 2026
Impaired SOX17 Expression Causes Endothelial Dysfunction and Pulmonary Arterial Hypertension by Insufficient Suppression of RUNX1.

|Apr 17, 2023
<i>SOX17</i> Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.

Rachel Walters, Eleni Vasilaki, Jurjan Aman

|Jan 12, 2022
Targeting RUNX1 as a novel treatment modality for pulmonary arterial hypertension.

Euy-Myoung Jeong, Mandy Pereira, Eui-Young So

|Jan 06, 2022
Effect of dose, dosing intervals, and hypoxic stress on the reversal of pulmonary hypertension by mesenchymal stem cell extracellular vesicles.

James R Klinger, Mandy Pereira, Michael Del Tatto

|Jul 21, 2021
Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice.

Eui-Young So, Changqi Sun, Keith Q Wu

|Nov 14, 2019
Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats.

James R Klinger, Mandy Pereira, Michael Del Tatto

Pageof 2

Frequent Collaborators

3 joint publications

James R Klinger

2 joint publications

Mandy Pereira

2 joint publications

Peter J Quesenberry

2 joint publications

John L Reagan